The C-C Chemokine Receptor Type 4 Is an Immunomodulatory Target of Hydroxychloroquine

The emergence of a severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2; COVID-19) in China, reported to the World Health Organization on December 31, 2019, has led to a large global pandemic and is a major public health issue. As a result, there are more than 200 clinical trials of COVID-19...

Descripción completa

Detalles Bibliográficos
Autores principales: Beck, Tyler C., Beck, Kyle R., Holloway, Calvin B., Hemings, Richard A., Dix, Thomas A., Norris, Russell A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7482581/
https://www.ncbi.nlm.nih.gov/pubmed/32973504
http://dx.doi.org/10.3389/fphar.2020.01253

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7482581/
https://www.ncbi.nlm.nih.gov/pubmed/32973504
http://dx.doi.org/10.3389/fphar.2020.01253

Ejemplares similares